share_log

Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Jayne David R.W.

Aurinia Pharmaceuticals | 4/A:持股變動聲明(修正)-董事 Jayne David R.W.

2022/07/11 06:16
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息